Physician profile
David M Krpata
NPI 1588826630
$7,366.83
in general payments reported to CMS, 2019-2025
20 companies · $1,252 in 2025
The $1,252 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,212 · 2020: $1,306 · 2021: $239 · 2022: $954 · 2023: $761 · 2024: $644 · 2025: $1,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,656.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $2,097.88 | 2019-2020 | |
| Medtronic, INC. | $1,085.58 | 2022-2025 | Signia, Ligasure, Progrip |
| W. L. Gore & Associates, INC. | $986.15 | 2019-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Davol INC. | $737.81 | 2019-2025 | Phasix Mesh, Bard 3dmax Mesh |
| Covidien LP | $669.33 | 2019-2020 | |
| Abbvie INC. | $186.75 | 2025 | |
| Integra Lifesciences Corporation | $184.99 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $165.88 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $162.72 | 2022 | |
| Innovation Technologies INC | $150.99 | 2025 | Irrisept |
| Becton, Dickinson and Company | $136.45 | 2025 | Phasix Mesh |
| C. R. Bard, INC. & Subsidiaries | $132.60 | 2022 | |
| Intuitive Surgical, INC. | $127.71 | 2022-2023 | Da Vinci Surgical System |
| Heron Therapeutics, INC. | $117.27 | 2021 | |
| Aroa Biosurgery Incorporated | $107.27 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $104.12 | 2022 | |
| Ethicon US, LLC | $98.17 | 2025 | Echelon; Endopath, Ethicon |
| Bard Access Systems, INC. | $68.83 | 2019 | |
| Distalmotion US | $34.93 | 2025 | Dexter L6 Robot |
| Cook Medical LLC | $11.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Krpata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.